Minerva Neurosciences, Inc
12.3.2026 12:00:00 CET | Globenewswire | Press release
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
BURLINGTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will participate in The Stifel 2026 Virtual CNS Forum being held March 17-18, 2026.
| The Stifel 2026 Virtual CNS Forum | |
| Format: | Company presentation |
| Day/Time: | Wednesday, March 18 at 8.30 AM ET |
| Webcast: | Webcast Link: |
| https://event.summitcast.com/view/4Ggc9Rmi4GQpDPGZwDp8g8/DdYPDYEQLLU6kp2AWRS6bu | |
If you are interested in a virtual meeting with the Minerva team during the conference, please reach out to your Stifel representative.
A replay of the presentation will be available on the Company's Investors & Media Events and Presentations webpage for ninety days following the event.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia. For more information, please visit the Company’s website.
Contacts:
Investor inquiries:
Frederick Ahlholm
Chief Financial Officer
Minerva Neurosciences, Inc.
FAhlholm@minervaneurosciences.com
Corey Davis, Ph.D.
LifeSci Advisors, LLC
212-915-2577
cdavis@lifesciadvisors.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S7.9.2026 13:12:37 CEST | Press release
Novo Nordisk A/S - share repurchase programme
Oma Säästöpankki Oyj7.9.2026 13:05:00 CEST | Press release
S-Bank Plc supplements the tender offer document dated 16 July 2026 regarding its voluntary public cash tender offer for all the shares in Oma Savings Bank Plc
Pro Kapital Grupp7.9.2026 13:00:00 CEST | Press release
Notice of public offering of AS Pro Kapital Grupp bonds
Novo Nordisk A/S7.9.2026 12:00:00 CEST | Press release
Novo Nordisk STEP Young phase 3 data: 40.4% of children living with obesity achieved a BMI below the obesity threshold with semaglutide and lifestyle modification
Holafly7.9.2026 11:30:00 CEST | Press release
Travelers could save up to 33% by choosing the right eSIM for their trip
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom